INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-AVIUM COMPLEX TO THE NEW FLUOROQUINOLONE SPARFLOXACIN (CI-978-AT-4140) AND COMPARISON WITH CIPROFLOXACIN

被引:29
作者
YAJKO, DM
SANDERS, CA
NASSOS, PS
HADLEY, WK
机构
[1] Dept. of Laboratory Medicine, University of California, San Francisco Gen. Hospital, San Francisco
关键词
D O I
10.1128/AAC.34.12.2442
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We tested the activity of the new fluoroquinolone sparfloxacin (CI-978; AT 4140) against 30 strains of Mycobacterium avium complex (MAC) isolated from patients with acquired immune deficiency syndrome. MICs of sparfloxacin (range, ≤0.06 to 4 μg/ml) were lower than MICs of ciprofloxacin for all 30 strains, and MBCs for acid-fast bacteria were lower for 28 of the 30 strains. In synergism experiments using 10 strains of MAC, fractional inhibitory concentration indices revealed that the combination of sparfloxacin plus ethambutol was synergistic against 9 strains, and the three-drug combination of sparfloxacin plus ethambutol plus rifampin was synergistic against all strains. In the absence of ethambutol, the combination of sparfloxacin plus rifampin appeared to be antagonistic against three of the MAC strains.
引用
收藏
页码:2442 / 2444
页数:3
相关论文
共 13 条
[1]   METHOD FOR TESTING FOR SYNERGY WITH ANY NUMBER OF AGENTS [J].
BERENBAUM, MC .
JOURNAL OF INFECTIOUS DISEASES, 1978, 137 (02) :122-130
[2]   COMPARATIVE INVITRO ACTIVITIES OF CIPROFLOXACIN AND OTHER 4-QUINOLONES AGAINST MYCOBACTERIUM-TUBERCULOSIS AND MYCOBACTERIUM-INTRACELLULARE [J].
FENLON, CH ;
CYNAMON, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (03) :386-388
[3]   SYNERGISM BETWEEN AMINOGLYCOSIDES AND CEPHALOSPORINS WITH ANTIPSEUDOMONAL ACTIVITY - INTERACTION INDEX AND KILLING CURVE METHOD [J].
HALLANDER, HO ;
DORNBUSCH, K ;
GEZELIUS, L ;
JACOBSON, K ;
KARLSSON, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (05) :743-752
[4]   MICS AND MBCS OF WIN 57273 AGAINST MYCOBACTERIUM-AVIUM AND MYCOBACTERIUM-TUBERCULOSIS [J].
HEIFETS, LB ;
LINDHOLMLEVY, PJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :770-774
[5]  
NAIK SP, 1989, DIAGN MICROBIOL INFE, V11, P11
[6]   INVITRO AND INVIVO ANTIBACTERIAL ACTIVITIES OF AT-4140, A NEW BROAD-SPECTRUM QUINOLONE [J].
NAKAMURA, S ;
MINAMI, A ;
NAKATA, K ;
KUROBE, N ;
KOUNO, K ;
SAKAGUCHI, Y ;
KASHIMOTO, S ;
YOSHIDA, H ;
KOJIMA, T ;
OHUE, T ;
FUJIMOTO, K ;
NAKAMURA, M ;
HASHIMOTO, M ;
SHIMIZU, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1167-1173
[7]   PHARMACOKINETICS OF A NOVEL QUINOLONE, AT-4140, IN ANIMALS [J].
NAKAMURA, S ;
KUROBE, N ;
OHUE, T ;
HASHIMOTO, M ;
SHIMIZU, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (01) :89-93
[8]   COMPARATIVE INVITRO ACTIVITY OF PD-127391, A NEW FLUORINATED 4-QUINOLONE DERIVATIVE [J].
NORRBY, SR ;
JONSSON, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1278-1281
[9]  
SNIDER DE, 1987, AM REV RESPIR DIS, V136, P492
[10]   INVITRO ACTIVITY OF PD-127391, AN ENHANCED-SPECTRUM QUINOLONE [J].
WISE, R ;
ASHBY, JP ;
ANDREWS, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1251-1256